Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06935071 · ClinicalTrials.gov registry record
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
A clinical trial of Hip Fractures and Pathological Fracture, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06935071 is a study of Hip Fractures and Pathological Fracture that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 300 participants, below the 601-participant average among 15 other Hip Fractures trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06935071, a study of Hip Fractures and Pathological Fracture, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compare rates ofambulation, pain, and survival to the historic cohort and (2) to identify predictors of ambulation in the current population.
Conditions Studied
Interventions
- OTHER Data Collection and Analysis
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-08-04 |
| Est. Completion | 2026-08-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06935071
The ClinicalTrials.gov registry entry for NCT06935071 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 601-participant average among 15 other Hip Fractures trials with a reported enrollment target (50% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hip Fractures appearing as the primary indexed condition, and to 1 intervention - of which Data Collection and Analysis is the first listed.
NCT06935071 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06935071 about?
NCT06935071 is a clinical study titled "Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update". This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compare rates ofambulation, pain, and survival to the historic cohort and (2) to identify predictors of am...
What is the current status of trial NCT06935071?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2016-08-04. Estimated completion is 2026-08-04.
What conditions does trial NCT06935071 study?
This clinical trial studies the following conditions: Hip Fractures, Pathological Fracture, Hip Fracture Pathologic, Pathological Fracture of Hip.
What interventions are being tested in trial NCT06935071?
The interventions under investigation include: Data Collection and Analysis (OTHER).
Who is sponsoring clinical trial NCT06935071?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06935071 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
RECRUITING · NA
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
RECRUITING · Phase 4
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
MDR - PMCF Study for Taperloc Complete Stems
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.